Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Inflammatory, Oxidative Stress, Neurogenic, and Immunological Biomarkers in Pulp Blood for the Differential Diagnosis of Reversible and Irreversible Pulpitis

NCT07658742 is registered in ClinicalTrials.gov with Safa as lead sponsor.

NCT NCT07658742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07658742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Inflammatory, Oxidative Stress, Neurogenic, and Immunological Biomarkers in Pulp Blood for the Differential Diagnosis of Reversible and Irreversible Pulpitis
Lead sponsor
Safa
Phase
Observational
Overall status
Completed
Start date
November 1, 2025
Completion date
June 10, 2026
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy pulp, irreversible pulpitis, reversible pulpitis